Status:
COMPLETED
A Safety Study to Investigate the Skin Sensitization Potential of MFC51123
Lead Sponsor:
GlaxoSmithKline
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This research study is being carried out to determine the possibility that a new medication causes allergic reactions. This new medication contains two active ingredients (diclofenac and menthol) toge...
Eligibility Criteria
Inclusion
- Healthy men or women participants with 18 years of age or older.
Exclusion
- Participants with a history of hypersensitivity, allergy with the use of NSAIDs or menthol or currently receiving systemic or topical NSAIDs within 3 days of visit 1.
- Participants having psoriasis and/or active atopic dermatitis/eczema, and skin infected.
- Lesions, burn or wound in the application site.
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2014
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT02192203
Start Date
April 1 2014
End Date
July 15 2014
Last Update
June 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TKL Research Inc
Paramus, New Jersey, United States, 07652